Breast CSCs, or tumor-initiating cells, can be isolated by the immuno-sorting of breast cancer cells that express the hyaluronian receptor CD44, a gene that is overexpressed in basal-like tumors [54] and lack the expression of CD24, an endogenous inhibitor of the chemokine receptor CXCR [21,55]. This evidence concerns the gene CD44 and breast cancer.